Index of reports
> Cases with Hypotension (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Spironolactone and Hydrochlorothiazide where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Spironolactone and Hydrochlorothiazide side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 62 year old male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Insulin Glargine
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Insulin Glargine
Start date: 2011-11-21
End date: 2012-05-15
Placebo
Indication: Type 2 Diabetes Mellitus
Lisinopril
Aspirin
Blinded Study Medication
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
End date: 2011-11-14
Insulin Glargine
Start date: 2012-05-16
Insulin Aspart
Start date: 2011-03-11
End date: 2011-06-02
Furosemide
Blinded Study Medication
Start date: 2011-12-05
Insulin Aspart
Start date: 2011-06-03
Isosorbide Mononitrate
Nifedipine
Spironolactone and Hydrochlorothiazide
Insulin Aspart
Indication: Type 2 Diabetes Mellitus
End date: 2011-03-10
Atenolol
Other drugs received by patient: Niacin
Possible Spironolactone and Hydrochlorothiazide side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 62 year old male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lantus
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Spironolactone and Hydrochlorothiazide
Lisinopril
Atenolol
Isosorbide Mononitrate
Insulin Aspart
Indication: Type 2 Diabetes Mellitus
End date: 2011-03-10
Insulin Aspart
Start date: 2011-03-11
End date: 2011-06-02
Insulin Aspart
Start date: 2011-06-03
Nifedipine
Placebo
Indication: Type 2 Diabetes Mellitus
Lantus
Start date: 2011-11-21
End date: 2012-05-15
Lantus
Start date: 2012-05-16
Blinded Study Medication
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
End date: 2011-11-14
Blinded Study Medication
Start date: 2011-12-05
Aspirin
Furosemide
Other drugs received by patient: Niacin
Possible Spironolactone and Hydrochlorothiazide side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: 62 year old male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atenolol
Blinded Study Medication
Start date: 2011-12-05
Spironolactone and Hydrochlorothiazide
Lantus
Start date: 2012-05-16
Lisinopril
Insulin Aspart
Indication: Type 2 Diabetes Mellitus
End date: 2011-03-10
Furosemide
Insulin Aspart
Start date: 2011-03-11
End date: 2011-06-02
Insulin Aspart
Start date: 2011-06-03
Aspirin
Nifedipine
Blinded Study Medication
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
End date: 2011-11-14
Lantus
Start date: 2011-11-21
End date: 2012-05-15
Placebo
Indication: Type 2 Diabetes Mellitus
Isosorbide Mononitrate
Lantus
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Other drugs received by patient: Niacin
Possible Spironolactone and Hydrochlorothiazide side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 62 year old male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Study Medication
Start date: 2011-12-05
Insulin Aspart
Indication: Type 2 Diabetes Mellitus
End date: 2011-03-10
Insulin Aspart
Start date: 2011-06-03
Spironolactone and Hydrochlorothiazide
Blinded Study Medication
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
End date: 2011-11-14
Lisinopril
Aspirin
Insulin Glargine
Start date: 2012-05-16
Atenolol
Insulin Glargine
Start date: 2011-11-21
End date: 2012-05-15
Placebo
Indication: Type 2 Diabetes Mellitus
Insulin Aspart
Start date: 2011-03-11
End date: 2011-06-02
Insulin Glargine
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Isosorbide Mononitrate
Furosemide
Nifedipine
Other drugs received by patient: Niacin
Possible Spironolactone and Hydrochlorothiazide side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 62 year old male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Study Medication
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
End date: 2011-11-14
Insulin Aspart
Indication: Type 2 Diabetes Mellitus
End date: 2011-03-10
Insulin Glargine
Start date: 2011-11-21
End date: 2012-05-15
Insulin Glargine
Start date: 2012-05-16
Nifedipine
Spironolactone and Hydrochlorothiazide
Blinded Study Medication
Start date: 2011-12-05
Placebo
Indication: Type 2 Diabetes Mellitus
Lisinopril
Atenolol
Insulin Aspart
Start date: 2011-06-03
Isosorbide Mononitrate
Insulin Aspart
Start date: 2011-03-11
End date: 2011-06-02
Insulin Glargine
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Aspirin
Furosemide
Other drugs received by patient: Niacin
Possible Spironolactone and Hydrochlorothiazide side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: 62 year old male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Insulin Glargine
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Blinded Study Medication
Start date: 2011-12-05
Insulin Aspart
Start date: 2011-06-03
Insulin Glargine
Start date: 2012-05-16
Nifedipine
Spironolactone and Hydrochlorothiazide
Insulin Aspart
Indication: Type 2 Diabetes Mellitus
End date: 2011-03-10
Atenolol
Blinded Study Medication
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
End date: 2011-11-14
Placebo
Indication: Type 2 Diabetes Mellitus
Insulin Glargine
Start date: 2011-11-21
End date: 2012-05-15
Lisinopril
Isosorbide Mononitrate
Aspirin
Insulin Aspart
Start date: 2011-03-11
End date: 2011-06-02
Furosemide
Other drugs received by patient: Niacin
Possible Spironolactone and Hydrochlorothiazide side effects in male
Reported by a physician from United States on 2012-06-07
Patient: male
Reactions: Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Spironolactone and Hydrochlorothiazide
Furosemide
Lisinopril
Isosorbide Mononitrate
Insulin Aspart
Dosage: 126 u
Start date: 2011-03-11
End date: 2011-06-02
Insulin Glargine
Dosage: 128 u
Start date: 2011-05-16
Atenolol
Acetylsalicylic Acid SRT
Insulin Aspart
Dosage: 120 u
Indication: Type 2 Diabetes Mellitus
Placebo
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
Insulin Glargine
Dosage: 128 u
Indication: Type 2 Diabetes Mellitus
Start date: 2011-08-11
End date: 2011-11-20
Insulin Glargine
Dosage: 140 u
Start date: 2011-11-21
End date: 2012-05-15
Saxagliptin
Indication: Type 2 Diabetes Mellitus
Start date: 2010-12-20
Insulin Aspart
Dosage: 150 u
Start date: 2012-06-03
Nifedipine
Other drugs received by patient: Niacin; Insulin; Insulin
|